3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1265

Change

+7.00 (+0.56)%

Market Cap

N/A

Volume

30.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-04 )

Largest Industry Peers for Other

ETFs Containing 3020-OL:HK

DXZ:CA Dynamic Active U.S. Mid-C.. 11.35 % 0.87 %

N/A

CAD 0.02B
TETF 6.19 % 0.64 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 5.07 % 0.75 %

N/A

CAD 0.09B
PSL Invesco DWA Consumer Stap.. 3.85 % 0.60 %

N/A

USD 0.08B
HDIV 2.83 % 0.00 %

N/A

N/A
RYH 1.72 % 0.40 %

N/A

N/A
IBCZ:F iShares IV Public Limited.. 1.45 % 0.00 %

N/A

USD 0.46B
HONR 1.20 % 0.65 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.72 % 0.40 %

N/A

CAD 0.35B
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.02B
DRFU:CA Desjardins RI USA Multifa.. 0.00 % 0.57 %

N/A

CAD 5.97M
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

N/A

USD 0.09B
RYF 0.00 % 0.40 %

N/A

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

N/A

USD 4.37B
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.24% 75% C 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.24% 73% C 77% C+
Trailing 12 Months  
Capital Gain 26.06% 84% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.06% 82% B 83% B
Trailing 5 Years  
Capital Gain 98.12% 85% B 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 98.12% 85% B 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 15.63% 80% B- 79% B-
Dividend Return 15.63% 78% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.55% 73% C 73% C
Risk Adjusted Return 79.95% 98% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike